Contact us : info@bioworlde.com
Home > Product > COVID-19&Infectious disease series
Andes orthohantavirus Nucleocapsid Protein(ANDV-NP) NCP0147
  • Andes orthohantavirus Nucleocapsid Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 85%.
Product NameAndes orthohantavirus Nucleocapsid Protein(ANDV-NP)
Catalog No.NCP0147
Swiss-ProtAF004660.1
Host His-tag
ReactivityE. coli Expression
ApplicationsReseach
Application_allReseach
BiowMW1287bp;47kDa
Purification&PurityTransferred into competent cells and the supernatant was purified by NI column affinity chromatography and the purity is > 85% (by SDS-PAGE).
Browse similar products>>
Size Price
100ug $398
1mg $2980
Add to cart My orders
Product Name :
Andes orthohantavirus Nucleocapsid Protein(ANDV-NP)
Background :
The sole confirmed etiologic agent of HCPS in Chile is Andes virus (ANDV). Human infection with this virus occurs from exposure to contaminated excreta and secretions of rodents of the family Cricetidae. Transmission of ANDV between rodents has been experimentally documented after exposure of seronegative rodents to inhalation of aerosolized infected rodent secretions. ANDV is endemic in Chile and Argentina and is the only hantavirus for which person-to-person transmission has been documented. Person-to-person transmission of ANDV occurs mainly in family clusters or, less commonly, after activities in which close contact with an infected case-patient has occurred, primarily during the disease prodrome.
Product :
Inclusion body;0.5mol Urea,PH=8
Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Specificity :
Carrier:pET30a-ANDV-NP-His(C-term) Virus:Andes virus S segment, nucleoprotein gene, complete cds
Immunogen :
pathway :
  • Andes orthohantavirus Nucleocapsid Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 85%.
Blocking peptide available as NCP0147P
COPYRIGHT © 2015-2018 Bioworld Technology, Inc. All rights reserved POLYCLONAL AND MONOCLONAL ANTIBODY CENTER